COVID-19 Impact on Global Nuclear Medicine Radioisotopes Market Insights, Forecast to 2026
Nuclear Medicine Radioisotopes market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Nuclear Medicine Radioisotopes market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Nuclear Medicine Radioisotopes market is segmented into
The Nuclear Medicine Radioisotopes market is analysed and market size information is provided by regions (countries).
The key regions covered in the Nuclear Medicine Radioisotopes market report are North America, Europe, China and Japan. It also covers key regions (countries), viz, the U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of production capacity, price and revenue for the period 2015-2026.
Competitive Landscape and Nuclear Medicine Radioisotopes Market Share Analysis
Nuclear Medicine Radioisotopes market competitive landscape provides details and data information by manufacturers. The report offers comprehensive analysis and accurate statistics on production capacity, price, revenue of Nuclear Medicine Radioisotopes by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on production, revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue, and the production capacity, price, revenue generated in Nuclear Medicine Radioisotopes business, the date to enter into the Nuclear Medicine Radioisotopes market, Nuclear Medicine Radioisotopes product introduction, recent developments, etc.
The major vendors covered:
Segment by Type, the Nuclear Medicine Radioisotopes market is segmented into
- Thallium-201 (Tl-201)
- Iodine (I-123)
- Fluorine-18
- Rubidium-82 (Rb-82)
- Other
- Tumor
- Heart Disease
- Lymphoma
- Thyroid Gland
- Other
The Nuclear Medicine Radioisotopes market is analysed and market size information is provided by regions (countries).
The key regions covered in the Nuclear Medicine Radioisotopes market report are North America, Europe, China and Japan. It also covers key regions (countries), viz, the U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of production capacity, price and revenue for the period 2015-2026.
Competitive Landscape and Nuclear Medicine Radioisotopes Market Share Analysis
Nuclear Medicine Radioisotopes market competitive landscape provides details and data information by manufacturers. The report offers comprehensive analysis and accurate statistics on production capacity, price, revenue of Nuclear Medicine Radioisotopes by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on production, revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue, and the production capacity, price, revenue generated in Nuclear Medicine Radioisotopes business, the date to enter into the Nuclear Medicine Radioisotopes market, Nuclear Medicine Radioisotopes product introduction, recent developments, etc.
The major vendors covered:
- Agfa-Gevaert Group
- Braco
- Cardiarc
- Cardinal Health
- CMR Naviscan (Gamma Medica Inc.)
- Curium
- Digirad
- GE Healthcare
- Nordion (Canada)
- NTP Radioisotopes SOC
- Positron
- Segami
1 STUDY COVERAGE
1.1 Nuclear Medicine Radioisotopes Product Introduction
1.2 Key Market Segments in This Study
1.3 Key Manufacturers Covered: Ranking of Global Top Nuclear Medicine Radioisotopes Manufacturers by Revenue in 2019
1.4 Market by Type
1.4.1 Global Nuclear Medicine Radioisotopes Market Size Growth Rate by Type
1.4.2 Thallium-201 (Tl-201)
1.4.3 Iodine (I-123)
1.4.4 Fluorine-18
1.4.5 Rubidium-82 (Rb-82)
1.4.6 Other
1.5 Market by Application
1.5.1 Global Nuclear Medicine Radioisotopes Market Size Growth Rate by Application
1.5.2 Tumor
1.5.3 Heart Disease
1.5.4 Lymphoma
1.5.5 Thyroid Gland
1.5.6 Other
1.6 Coronavirus Disease 2019 (Covid-19): Nuclear Medicine Radioisotopes Industry Impact
1.6.1 How the Covid-19 is Affecting the Nuclear Medicine Radioisotopes Industry
1.6.1.1 Nuclear Medicine Radioisotopes Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Nuclear Medicine Radioisotopes Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Nuclear Medicine Radioisotopes Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Nuclear Medicine Radioisotopes Market Size Estimates and Forecasts
2.1.1 Global Nuclear Medicine Radioisotopes Revenue Estimates and Forecasts 2015-2026
2.1.2 Global Nuclear Medicine Radioisotopes Production Capacity Estimates and Forecasts 2015-2026
2.1.3 Global Nuclear Medicine Radioisotopes Production Estimates and Forecasts 2015-2026
2.2 Global Nuclear Medicine Radioisotopes Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Analysis of Competitive Landscape
2.3.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
2.3.2 Global Nuclear Medicine Radioisotopes Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.3.3 Global Nuclear Medicine Radioisotopes Manufacturers Geographical Distribution
2.4 Key Trends for Nuclear Medicine Radioisotopes Markets & Products
2.5 Primary Interviews with Key Nuclear Medicine Radioisotopes Players (Opinion Leaders)
3 MARKET SIZE BY MANUFACTURERS
3.1 Global Top Nuclear Medicine Radioisotopes Manufacturers by Production Capacity
3.1.1 Global Top Nuclear Medicine Radioisotopes Manufacturers by Production Capacity (2015-2020)
3.1.2 Global Top Nuclear Medicine Radioisotopes Manufacturers by Production (2015-2020)
3.1.3 Global Top Nuclear Medicine Radioisotopes Manufacturers Market Share by Production
3.2 Global Top Nuclear Medicine Radioisotopes Manufacturers by Revenue
3.2.1 Global Top Nuclear Medicine Radioisotopes Manufacturers by Revenue (2015-2020)
3.2.2 Global Top Nuclear Medicine Radioisotopes Manufacturers Market Share by Revenue (2015-2020)
3.2.3 Global Top 10 and Top 5 Companies by Nuclear Medicine Radioisotopes Revenue in 2019
3.3 Global Nuclear Medicine Radioisotopes Price by Manufacturers
3.4 Mergers & Acquisitions, Expansion Plans
4 NUCLEAR MEDICINE RADIOISOTOPES PRODUCTION BY REGIONS
4.1 Global Nuclear Medicine Radioisotopes Historic Market Facts & Figures by Regions
4.1.1 Global Top Nuclear Medicine Radioisotopes Regions by Production (2015-2020)
4.1.2 Global Top Nuclear Medicine Radioisotopes Regions by Revenue (2015-2020)
4.2 North America
4.2.1 North America Nuclear Medicine Radioisotopes Production (2015-2020)
4.2.2 North America Nuclear Medicine Radioisotopes Revenue (2015-2020)
4.2.3 Key Players in North America
4.2.4 North America Nuclear Medicine Radioisotopes Import & Export (2015-2020)
4.3 Europe
4.3.1 Europe Nuclear Medicine Radioisotopes Production (2015-2020)
4.3.2 Europe Nuclear Medicine Radioisotopes Revenue (2015-2020)
4.3.3 Key Players in Europe
4.3.4 Europe Nuclear Medicine Radioisotopes Import & Export (2015-2020)
4.4 China
4.4.1 China Nuclear Medicine Radioisotopes Production (2015-2020)
4.4.2 China Nuclear Medicine Radioisotopes Revenue (2015-2020)
4.4.3 Key Players in China
4.4.4 China Nuclear Medicine Radioisotopes Import & Export (2015-2020)
4.5 Japan
4.5.1 Japan Nuclear Medicine Radioisotopes Production (2015-2020)
4.5.2 Japan Nuclear Medicine Radioisotopes Revenue (2015-2020)
4.5.3 Key Players in Japan
4.5.4 Japan Nuclear Medicine Radioisotopes Import & Export (2015-2020)
5 NUCLEAR MEDICINE RADIOISOTOPES CONSUMPTION BY REGION
5.1 Global Top Nuclear Medicine Radioisotopes Regions by Consumption
5.1.1 Global Top Nuclear Medicine Radioisotopes Regions by Consumption (2015-2020)
5.1.2 Global Top Nuclear Medicine Radioisotopes Regions Market Share by Consumption (2015-2020)
5.2 North America
5.2.1 North America Nuclear Medicine Radioisotopes Consumption by Application
5.2.2 North America Nuclear Medicine Radioisotopes Consumption by Countries
5.2.3 U.S.
5.2.4 Canada
5.3 Europe
5.3.1 Europe Nuclear Medicine Radioisotopes Consumption by Application
5.3.2 Europe Nuclear Medicine Radioisotopes Consumption by Countries
5.3.3 Germany
5.3.4 France
5.3.5 U.K.
5.3.6 Italy
5.3.7 Russia
5.4 Asia Pacific
5.4.1 Asia Pacific Nuclear Medicine Radioisotopes Consumption by Application
5.4.2 Asia Pacific Nuclear Medicine Radioisotopes Consumption by Regions
5.4.3 China
5.4.4 Japan
5.4.5 South Korea
5.4.6 India
5.4.7 Australia
5.4.8 Taiwan
5.4.9 Indonesia
5.4.10 Thailand
5.4.11 Malaysia
5.4.12 Philippines
5.4.13 Vietnam
5.5 Central & South America
5.5.1 Central & South America Nuclear Medicine Radioisotopes Consumption by Application
5.5.2 Central & South America Nuclear Medicine Radioisotopes Consumption by Country
5.5.3 Mexico
5.5.3 Brazil
5.5.3 Argentina
5.6 Middle East and Africa
5.6.1 Middle East and Africa Nuclear Medicine Radioisotopes Consumption by Application
5.6.2 Middle East and Africa Nuclear Medicine Radioisotopes Consumption by Countries
5.6.3 Turkey
5.6.4 Saudi Arabia
5.6.5 U.A.E
6 MARKET SIZE BY TYPE (2015-2026)
6.1 Global Nuclear Medicine Radioisotopes Market Size by Type (2015-2020)
6.1.1 Global Nuclear Medicine Radioisotopes Production by Type (2015-2020)
6.1.2 Global Nuclear Medicine Radioisotopes Revenue by Type (2015-2020)
6.1.3 Nuclear Medicine Radioisotopes Price by Type (2015-2020)
6.2 Global Nuclear Medicine Radioisotopes Market Forecast by Type (2021-2026)
6.2.1 Global Nuclear Medicine Radioisotopes Production Forecast by Type (2021-2026)
6.2.2 Global Nuclear Medicine Radioisotopes Revenue Forecast by Type (2021-2026)
6.2.3 Global Nuclear Medicine Radioisotopes Price Forecast by Type (2021-2026)
6.3 Global Nuclear Medicine Radioisotopes Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
7 MARKET SIZE BY APPLICATION (2015-2026)
7.2.1 Global Nuclear Medicine Radioisotopes Consumption Historic Breakdown by Application (2015-2020)
7.2.2 Global Nuclear Medicine Radioisotopes Consumption Forecast by Application (2021-2026)
8 CORPORATE PROFILES
8.1 Agfa-Gevaert Group
8.1.1 Agfa-Gevaert Group Corporation Information
8.1.2 Agfa-Gevaert Group Overview and Its Total Revenue
8.1.3 Agfa-Gevaert Group Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.1.4 Agfa-Gevaert Group Product Description
8.1.5 Agfa-Gevaert Group Recent Development
8.2 Braco
8.2.1 Braco Corporation Information
8.2.2 Braco Overview and Its Total Revenue
8.2.3 Braco Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.2.4 Braco Product Description
8.2.5 Braco Recent Development
8.3 Cardiarc
8.3.1 Cardiarc Corporation Information
8.3.2 Cardiarc Overview and Its Total Revenue
8.3.3 Cardiarc Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.3.4 Cardiarc Product Description
8.3.5 Cardiarc Recent Development
8.4 Cardinal Health
8.4.1 Cardinal Health Corporation Information
8.4.2 Cardinal Health Overview and Its Total Revenue
8.4.3 Cardinal Health Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.4.4 Cardinal Health Product Description
8.4.5 Cardinal Health Recent Development
8.5 CMR Naviscan (Gamma Medica Inc.)
8.5.1 CMR Naviscan (Gamma Medica Inc.) Corporation Information
8.5.2 CMR Naviscan (Gamma Medica Inc.) Overview and Its Total Revenue
8.5.3 CMR Naviscan (Gamma Medica Inc.) Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.5.4 CMR Naviscan (Gamma Medica Inc.) Product Description
8.5.5 CMR Naviscan (Gamma Medica Inc.) Recent Development
8.6 Curium
8.6.1 Curium Corporation Information
8.6.2 Curium Overview and Its Total Revenue
8.6.3 Curium Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.6.4 Curium Product Description
8.6.5 Curium Recent Development
8.7 Digirad
8.7.1 Digirad Corporation Information
8.7.2 Digirad Overview and Its Total Revenue
8.7.3 Digirad Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.7.4 Digirad Product Description
8.7.5 Digirad Recent Development
8.8 GE Healthcare
8.8.1 GE Healthcare Corporation Information
8.8.2 GE Healthcare Overview and Its Total Revenue
8.8.3 GE Healthcare Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.8.4 GE Healthcare Product Description
8.8.5 GE Healthcare Recent Development
8.9 Nordion (Canada)
8.9.1 Nordion (Canada) Corporation Information
8.9.2 Nordion (Canada) Overview and Its Total Revenue
8.9.3 Nordion (Canada) Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.9.4 Nordion (Canada) Product Description
8.9.5 Nordion (Canada) Recent Development
8.10 NTP Radioisotopes SOC
8.10.1 NTP Radioisotopes SOC Corporation Information
8.10.2 NTP Radioisotopes SOC Overview and Its Total Revenue
8.10.3 NTP Radioisotopes SOC Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.10.4 NTP Radioisotopes SOC Product Description
8.10.5 NTP Radioisotopes SOC Recent Development
8.11 Positron
8.11.1 Positron Corporation Information
8.11.2 Positron Overview and Its Total Revenue
8.11.3 Positron Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.11.4 Positron Product Description
8.11.5 Positron Recent Development
8.12 Segami
8.12.1 Segami Corporation Information
8.12.2 Segami Overview and Its Total Revenue
8.12.3 Segami Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.12.4 Segami Product Description
8.12.5 Segami Recent Development
8.13 Siemens Healthcare
8.13.1 Siemens Healthcare Corporation Information
8.13.2 Siemens Healthcare Overview and Its Total Revenue
8.13.3 Siemens Healthcare Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.13.4 Siemens Healthcare Product Description
8.13.5 Siemens Healthcare Recent Development
9 PRODUCTION FORECASTS BY REGIONS
9.1 Global Top Nuclear Medicine Radioisotopes Regions Forecast by Revenue (2021-2026)
9.2 Global Top Nuclear Medicine Radioisotopes Regions Forecast by Production (2021-2026)
9.3 Key Nuclear Medicine Radioisotopes Production Regions Forecast
9.3.1 North America
9.3.2 Europe
9.3.3 China
9.3.4 Japan
10 NUCLEAR MEDICINE RADIOISOTOPES CONSUMPTION FORECAST BY REGION
10.1 Global Nuclear Medicine Radioisotopes Consumption Forecast by Region (2021-2026)
10.2 North America Nuclear Medicine Radioisotopes Consumption Forecast by Region (2021-2026)
10.3 Europe Nuclear Medicine Radioisotopes Consumption Forecast by Region (2021-2026)
10.4 Asia Pacific Nuclear Medicine Radioisotopes Consumption Forecast by Region (2021-2026)
10.5 Latin America Nuclear Medicine Radioisotopes Consumption Forecast by Region (2021-2026)
10.6 Middle East and Africa Nuclear Medicine Radioisotopes Consumption Forecast by Region (2021-2026)
11 VALUE CHAIN AND SALES CHANNELS ANALYSIS
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Nuclear Medicine Radioisotopes Sales Channels
11.2.2 Nuclear Medicine Radioisotopes Distributors
11.3 Nuclear Medicine Radioisotopes Customers
12 MARKET OPPORTUNITIES & CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
12.1 Market Opportunities and Drivers
12.2 Market Challenges
12.3 Market Risks/Restraints
12.4 Porter's Five Forces Analysis
13 KEY FINDING IN THE GLOBAL NUCLEAR MEDICINE RADIOISOTOPES STUDY
14 APPENDIX
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
1.1 Nuclear Medicine Radioisotopes Product Introduction
1.2 Key Market Segments in This Study
1.3 Key Manufacturers Covered: Ranking of Global Top Nuclear Medicine Radioisotopes Manufacturers by Revenue in 2019
1.4 Market by Type
1.4.1 Global Nuclear Medicine Radioisotopes Market Size Growth Rate by Type
1.4.2 Thallium-201 (Tl-201)
1.4.3 Iodine (I-123)
1.4.4 Fluorine-18
1.4.5 Rubidium-82 (Rb-82)
1.4.6 Other
1.5 Market by Application
1.5.1 Global Nuclear Medicine Radioisotopes Market Size Growth Rate by Application
1.5.2 Tumor
1.5.3 Heart Disease
1.5.4 Lymphoma
1.5.5 Thyroid Gland
1.5.6 Other
1.6 Coronavirus Disease 2019 (Covid-19): Nuclear Medicine Radioisotopes Industry Impact
1.6.1 How the Covid-19 is Affecting the Nuclear Medicine Radioisotopes Industry
1.6.1.1 Nuclear Medicine Radioisotopes Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Nuclear Medicine Radioisotopes Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Nuclear Medicine Radioisotopes Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Nuclear Medicine Radioisotopes Market Size Estimates and Forecasts
2.1.1 Global Nuclear Medicine Radioisotopes Revenue Estimates and Forecasts 2015-2026
2.1.2 Global Nuclear Medicine Radioisotopes Production Capacity Estimates and Forecasts 2015-2026
2.1.3 Global Nuclear Medicine Radioisotopes Production Estimates and Forecasts 2015-2026
2.2 Global Nuclear Medicine Radioisotopes Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Analysis of Competitive Landscape
2.3.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
2.3.2 Global Nuclear Medicine Radioisotopes Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.3.3 Global Nuclear Medicine Radioisotopes Manufacturers Geographical Distribution
2.4 Key Trends for Nuclear Medicine Radioisotopes Markets & Products
2.5 Primary Interviews with Key Nuclear Medicine Radioisotopes Players (Opinion Leaders)
3 MARKET SIZE BY MANUFACTURERS
3.1 Global Top Nuclear Medicine Radioisotopes Manufacturers by Production Capacity
3.1.1 Global Top Nuclear Medicine Radioisotopes Manufacturers by Production Capacity (2015-2020)
3.1.2 Global Top Nuclear Medicine Radioisotopes Manufacturers by Production (2015-2020)
3.1.3 Global Top Nuclear Medicine Radioisotopes Manufacturers Market Share by Production
3.2 Global Top Nuclear Medicine Radioisotopes Manufacturers by Revenue
3.2.1 Global Top Nuclear Medicine Radioisotopes Manufacturers by Revenue (2015-2020)
3.2.2 Global Top Nuclear Medicine Radioisotopes Manufacturers Market Share by Revenue (2015-2020)
3.2.3 Global Top 10 and Top 5 Companies by Nuclear Medicine Radioisotopes Revenue in 2019
3.3 Global Nuclear Medicine Radioisotopes Price by Manufacturers
3.4 Mergers & Acquisitions, Expansion Plans
4 NUCLEAR MEDICINE RADIOISOTOPES PRODUCTION BY REGIONS
4.1 Global Nuclear Medicine Radioisotopes Historic Market Facts & Figures by Regions
4.1.1 Global Top Nuclear Medicine Radioisotopes Regions by Production (2015-2020)
4.1.2 Global Top Nuclear Medicine Radioisotopes Regions by Revenue (2015-2020)
4.2 North America
4.2.1 North America Nuclear Medicine Radioisotopes Production (2015-2020)
4.2.2 North America Nuclear Medicine Radioisotopes Revenue (2015-2020)
4.2.3 Key Players in North America
4.2.4 North America Nuclear Medicine Radioisotopes Import & Export (2015-2020)
4.3 Europe
4.3.1 Europe Nuclear Medicine Radioisotopes Production (2015-2020)
4.3.2 Europe Nuclear Medicine Radioisotopes Revenue (2015-2020)
4.3.3 Key Players in Europe
4.3.4 Europe Nuclear Medicine Radioisotopes Import & Export (2015-2020)
4.4 China
4.4.1 China Nuclear Medicine Radioisotopes Production (2015-2020)
4.4.2 China Nuclear Medicine Radioisotopes Revenue (2015-2020)
4.4.3 Key Players in China
4.4.4 China Nuclear Medicine Radioisotopes Import & Export (2015-2020)
4.5 Japan
4.5.1 Japan Nuclear Medicine Radioisotopes Production (2015-2020)
4.5.2 Japan Nuclear Medicine Radioisotopes Revenue (2015-2020)
4.5.3 Key Players in Japan
4.5.4 Japan Nuclear Medicine Radioisotopes Import & Export (2015-2020)
5 NUCLEAR MEDICINE RADIOISOTOPES CONSUMPTION BY REGION
5.1 Global Top Nuclear Medicine Radioisotopes Regions by Consumption
5.1.1 Global Top Nuclear Medicine Radioisotopes Regions by Consumption (2015-2020)
5.1.2 Global Top Nuclear Medicine Radioisotopes Regions Market Share by Consumption (2015-2020)
5.2 North America
5.2.1 North America Nuclear Medicine Radioisotopes Consumption by Application
5.2.2 North America Nuclear Medicine Radioisotopes Consumption by Countries
5.2.3 U.S.
5.2.4 Canada
5.3 Europe
5.3.1 Europe Nuclear Medicine Radioisotopes Consumption by Application
5.3.2 Europe Nuclear Medicine Radioisotopes Consumption by Countries
5.3.3 Germany
5.3.4 France
5.3.5 U.K.
5.3.6 Italy
5.3.7 Russia
5.4 Asia Pacific
5.4.1 Asia Pacific Nuclear Medicine Radioisotopes Consumption by Application
5.4.2 Asia Pacific Nuclear Medicine Radioisotopes Consumption by Regions
5.4.3 China
5.4.4 Japan
5.4.5 South Korea
5.4.6 India
5.4.7 Australia
5.4.8 Taiwan
5.4.9 Indonesia
5.4.10 Thailand
5.4.11 Malaysia
5.4.12 Philippines
5.4.13 Vietnam
5.5 Central & South America
5.5.1 Central & South America Nuclear Medicine Radioisotopes Consumption by Application
5.5.2 Central & South America Nuclear Medicine Radioisotopes Consumption by Country
5.5.3 Mexico
5.5.3 Brazil
5.5.3 Argentina
5.6 Middle East and Africa
5.6.1 Middle East and Africa Nuclear Medicine Radioisotopes Consumption by Application
5.6.2 Middle East and Africa Nuclear Medicine Radioisotopes Consumption by Countries
5.6.3 Turkey
5.6.4 Saudi Arabia
5.6.5 U.A.E
6 MARKET SIZE BY TYPE (2015-2026)
6.1 Global Nuclear Medicine Radioisotopes Market Size by Type (2015-2020)
6.1.1 Global Nuclear Medicine Radioisotopes Production by Type (2015-2020)
6.1.2 Global Nuclear Medicine Radioisotopes Revenue by Type (2015-2020)
6.1.3 Nuclear Medicine Radioisotopes Price by Type (2015-2020)
6.2 Global Nuclear Medicine Radioisotopes Market Forecast by Type (2021-2026)
6.2.1 Global Nuclear Medicine Radioisotopes Production Forecast by Type (2021-2026)
6.2.2 Global Nuclear Medicine Radioisotopes Revenue Forecast by Type (2021-2026)
6.2.3 Global Nuclear Medicine Radioisotopes Price Forecast by Type (2021-2026)
6.3 Global Nuclear Medicine Radioisotopes Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
7 MARKET SIZE BY APPLICATION (2015-2026)
7.2.1 Global Nuclear Medicine Radioisotopes Consumption Historic Breakdown by Application (2015-2020)
7.2.2 Global Nuclear Medicine Radioisotopes Consumption Forecast by Application (2021-2026)
8 CORPORATE PROFILES
8.1 Agfa-Gevaert Group
8.1.1 Agfa-Gevaert Group Corporation Information
8.1.2 Agfa-Gevaert Group Overview and Its Total Revenue
8.1.3 Agfa-Gevaert Group Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.1.4 Agfa-Gevaert Group Product Description
8.1.5 Agfa-Gevaert Group Recent Development
8.2 Braco
8.2.1 Braco Corporation Information
8.2.2 Braco Overview and Its Total Revenue
8.2.3 Braco Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.2.4 Braco Product Description
8.2.5 Braco Recent Development
8.3 Cardiarc
8.3.1 Cardiarc Corporation Information
8.3.2 Cardiarc Overview and Its Total Revenue
8.3.3 Cardiarc Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.3.4 Cardiarc Product Description
8.3.5 Cardiarc Recent Development
8.4 Cardinal Health
8.4.1 Cardinal Health Corporation Information
8.4.2 Cardinal Health Overview and Its Total Revenue
8.4.3 Cardinal Health Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.4.4 Cardinal Health Product Description
8.4.5 Cardinal Health Recent Development
8.5 CMR Naviscan (Gamma Medica Inc.)
8.5.1 CMR Naviscan (Gamma Medica Inc.) Corporation Information
8.5.2 CMR Naviscan (Gamma Medica Inc.) Overview and Its Total Revenue
8.5.3 CMR Naviscan (Gamma Medica Inc.) Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.5.4 CMR Naviscan (Gamma Medica Inc.) Product Description
8.5.5 CMR Naviscan (Gamma Medica Inc.) Recent Development
8.6 Curium
8.6.1 Curium Corporation Information
8.6.2 Curium Overview and Its Total Revenue
8.6.3 Curium Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.6.4 Curium Product Description
8.6.5 Curium Recent Development
8.7 Digirad
8.7.1 Digirad Corporation Information
8.7.2 Digirad Overview and Its Total Revenue
8.7.3 Digirad Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.7.4 Digirad Product Description
8.7.5 Digirad Recent Development
8.8 GE Healthcare
8.8.1 GE Healthcare Corporation Information
8.8.2 GE Healthcare Overview and Its Total Revenue
8.8.3 GE Healthcare Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.8.4 GE Healthcare Product Description
8.8.5 GE Healthcare Recent Development
8.9 Nordion (Canada)
8.9.1 Nordion (Canada) Corporation Information
8.9.2 Nordion (Canada) Overview and Its Total Revenue
8.9.3 Nordion (Canada) Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.9.4 Nordion (Canada) Product Description
8.9.5 Nordion (Canada) Recent Development
8.10 NTP Radioisotopes SOC
8.10.1 NTP Radioisotopes SOC Corporation Information
8.10.2 NTP Radioisotopes SOC Overview and Its Total Revenue
8.10.3 NTP Radioisotopes SOC Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.10.4 NTP Radioisotopes SOC Product Description
8.10.5 NTP Radioisotopes SOC Recent Development
8.11 Positron
8.11.1 Positron Corporation Information
8.11.2 Positron Overview and Its Total Revenue
8.11.3 Positron Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.11.4 Positron Product Description
8.11.5 Positron Recent Development
8.12 Segami
8.12.1 Segami Corporation Information
8.12.2 Segami Overview and Its Total Revenue
8.12.3 Segami Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.12.4 Segami Product Description
8.12.5 Segami Recent Development
8.13 Siemens Healthcare
8.13.1 Siemens Healthcare Corporation Information
8.13.2 Siemens Healthcare Overview and Its Total Revenue
8.13.3 Siemens Healthcare Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.13.4 Siemens Healthcare Product Description
8.13.5 Siemens Healthcare Recent Development
9 PRODUCTION FORECASTS BY REGIONS
9.1 Global Top Nuclear Medicine Radioisotopes Regions Forecast by Revenue (2021-2026)
9.2 Global Top Nuclear Medicine Radioisotopes Regions Forecast by Production (2021-2026)
9.3 Key Nuclear Medicine Radioisotopes Production Regions Forecast
9.3.1 North America
9.3.2 Europe
9.3.3 China
9.3.4 Japan
10 NUCLEAR MEDICINE RADIOISOTOPES CONSUMPTION FORECAST BY REGION
10.1 Global Nuclear Medicine Radioisotopes Consumption Forecast by Region (2021-2026)
10.2 North America Nuclear Medicine Radioisotopes Consumption Forecast by Region (2021-2026)
10.3 Europe Nuclear Medicine Radioisotopes Consumption Forecast by Region (2021-2026)
10.4 Asia Pacific Nuclear Medicine Radioisotopes Consumption Forecast by Region (2021-2026)
10.5 Latin America Nuclear Medicine Radioisotopes Consumption Forecast by Region (2021-2026)
10.6 Middle East and Africa Nuclear Medicine Radioisotopes Consumption Forecast by Region (2021-2026)
11 VALUE CHAIN AND SALES CHANNELS ANALYSIS
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Nuclear Medicine Radioisotopes Sales Channels
11.2.2 Nuclear Medicine Radioisotopes Distributors
11.3 Nuclear Medicine Radioisotopes Customers
12 MARKET OPPORTUNITIES & CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
12.1 Market Opportunities and Drivers
12.2 Market Challenges
12.3 Market Risks/Restraints
12.4 Porter's Five Forces Analysis
13 KEY FINDING IN THE GLOBAL NUCLEAR MEDICINE RADIOISOTOPES STUDY
14 APPENDIX
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
LIST OF TABLES
Table 1. Nuclear Medicine Radioisotopes Key Market Segments in This Study
Table 2. Ranking of Global Top Nuclear Medicine Radioisotopes Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Nuclear Medicine Radioisotopes Market Size Growth Rate by Type 2020-2026 (K Units) (Million US$)
Table 4. Major Manufacturers of Thallium-201 (Tl-201)
Table 5. Major Manufacturers of Iodine (I-123)
Table 6. Major Manufacturers of Fluorine-18
Table 7. Major Manufacturers of Rubidium-82 (Rb-82)
Table 8. Major Manufacturers of Other
Table 9. COVID-19 Impact Global Market: (Four Nuclear Medicine Radioisotopes Market Size Forecast Scenarios)
Table 10. Opportunities and Trends for Nuclear Medicine Radioisotopes Players in the COVID-19 Landscape
Table 11. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 12. Key Regions/Countries Measures against Covid-19 Impact
Table 13. Proposal for Nuclear Medicine Radioisotopes Players to Combat Covid-19 Impact
Table 14. Global Nuclear Medicine Radioisotopes Market Size Growth Rate by Application 2020-2026 (K Units)
Table 15. Global Nuclear Medicine Radioisotopes Market Size by Region in US$ Million: 2015 VS 2020 VS 2026
Table 16. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global Nuclear Medicine Radioisotopes by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Nuclear Medicine Radioisotopes as of 2019)
Table 18. Nuclear Medicine Radioisotopes Manufacturing Base Distribution and Headquarters
Table 19. Manufacturers Nuclear Medicine Radioisotopes Product Offered
Table 20. Date of Manufacturers Enter into Nuclear Medicine Radioisotopes Market
Table 21. Key Trends for Nuclear Medicine Radioisotopes Markets & Products
Table 22. Main Points Interviewed from Key Nuclear Medicine Radioisotopes Players
Table 23. Global Nuclear Medicine Radioisotopes Production Capacity by Manufacturers (2015-2020) (K Units)
Table 24. Global Nuclear Medicine Radioisotopes Production Share by Manufacturers (2015-2020)
Table 25. Nuclear Medicine Radioisotopes Revenue by Manufacturers (2015-2020) (Million US$)
Table 26. Nuclear Medicine Radioisotopes Revenue Share by Manufacturers (2015-2020)
Table 27. Nuclear Medicine Radioisotopes Price by Manufacturers 2015-2020 (USD/Unit)
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Nuclear Medicine Radioisotopes Production by Regions (2015-2020) (K Units)
Table 30. Global Nuclear Medicine Radioisotopes Production Market Share by Regions (2015-2020)
Table 31. Global Nuclear Medicine Radioisotopes Revenue by Regions (2015-2020) (US$ Million)
Table 32. Global Nuclear Medicine Radioisotopes Revenue Market Share by Regions (2015-2020)
Table 33. Key Nuclear Medicine Radioisotopes Players in North America
Table 34. Import & Export of Nuclear Medicine Radioisotopes in North America (K Units)
Table 35. Key Nuclear Medicine Radioisotopes Players in Europe
Table 36. Import & Export of Nuclear Medicine Radioisotopes in Europe (K Units)
Table 37. Key Nuclear Medicine Radioisotopes Players in China
Table 38. Import & Export of Nuclear Medicine Radioisotopes in China (K Units)
Table 39. Key Nuclear Medicine Radioisotopes Players in Japan
Table 40. Import & Export of Nuclear Medicine Radioisotopes in Japan (K Units)
Table 41. Global Nuclear Medicine Radioisotopes Consumption by Regions (2015-2020) (K Units)
Table 42. Global Nuclear Medicine Radioisotopes Consumption Market Share by Regions (2015-2020)
Table 43. North America Nuclear Medicine Radioisotopes Consumption by Application (2015-2020) (K Units)
Table 44. North America Nuclear Medicine Radioisotopes Consumption by Countries (2015-2020) (K Units)
Table 45. Europe Nuclear Medicine Radioisotopes Consumption by Application (2015-2020) (K Units)
Table 46. Europe Nuclear Medicine Radioisotopes Consumption by Countries (2015-2020) (K Units)
Table 47. Asia Pacific Nuclear Medicine Radioisotopes Consumption by Application (2015-2020) (K Units)
Table 48. Asia Pacific Nuclear Medicine Radioisotopes Consumption Market Share by Application (2015-2020) (K Units)
Table 49. Asia Pacific Nuclear Medicine Radioisotopes Consumption by Regions (2015-2020) (K Units)
Table 50. Latin America Nuclear Medicine Radioisotopes Consumption by Application (2015-2020) (K Units)
Table 51. Latin America Nuclear Medicine Radioisotopes Consumption by Countries (2015-2020) (K Units)
Table 52. Middle East and Africa Nuclear Medicine Radioisotopes Consumption by Application (2015-2020) (K Units)
Table 53. Middle East and Africa Nuclear Medicine Radioisotopes Consumption by Countries (2015-2020) (K Units)
Table 54. Global Nuclear Medicine Radioisotopes Production by Type (2015-2020) (K Units)
Table 55. Global Nuclear Medicine Radioisotopes Production Share by Type (2015-2020)
Table 56. Global Nuclear Medicine Radioisotopes Revenue by Type (2015-2020) (Million US$)
Table 57. Global Nuclear Medicine Radioisotopes Revenue Share by Type (2015-2020)
Table 58. Nuclear Medicine Radioisotopes Price by Type 2015-2020 (USD/Unit)
Table 59. Global Nuclear Medicine Radioisotopes Consumption by Application (2015-2020) (K Units)
Table 60. Global Nuclear Medicine Radioisotopes Consumption by Application (2015-2020) (K Units)
Table 61. Global Nuclear Medicine Radioisotopes Consumption Share by Application (2015-2020)
Table 62. Agfa-Gevaert Group Corporation Information
Table 63. Agfa-Gevaert Group Description and Major Businesses
Table 64. Agfa-Gevaert Group Nuclear Medicine Radioisotopes Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 65. Agfa-Gevaert Group Product
Table 66. Agfa-Gevaert Group Recent Development
Table 67. Braco Corporation Information
Table 68. Braco Description and Major Businesses
Table 69. Braco Nuclear Medicine Radioisotopes Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 70. Braco Product
Table 71. Braco Recent Development
Table 72. Cardiarc Corporation Information
Table 73. Cardiarc Description and Major Businesses
Table 74. Cardiarc Nuclear Medicine Radioisotopes Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 75. Cardiarc Product
Table 76. Cardiarc Recent Development
Table 77. Cardinal Health Corporation Information
Table 78. Cardinal Health Description and Major Businesses
Table 79. Cardinal Health Nuclear Medicine Radioisotopes Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 80. Cardinal Health Product
Table 81. Cardinal Health Recent Development
Table 82. CMR Naviscan (Gamma Medica Inc.) Corporation Information
Table 83. CMR Naviscan (Gamma Medica Inc.) Description and Major Businesses
Table 84. CMR Naviscan (Gamma Medica Inc.) Nuclear Medicine Radioisotopes Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 85. CMR Naviscan (Gamma Medica Inc.) Product
Table 86. CMR Naviscan (Gamma Medica Inc.) Recent Development
Table 87. Curium Corporation Information
Table 88. Curium Description and Major Businesses
Table 89. Curium Nuclear Medicine Radioisotopes Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 90. Curium Product
Table 91. Curium Recent Development
Table 92. Digirad Corporation Information
Table 93. Digirad Description and Major Businesses
Table 94. Digirad Nuclear Medicine Radioisotopes Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 95. Digirad Product
Table 96. Digirad Recent Development
Table 97. GE Healthcare Corporation Information
Table 98. GE Healthcare Description and Major Businesses
Table 99. GE Healthcare Nuclear Medicine Radioisotopes Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 100. GE Healthcare Product
Table 101. GE Healthcare Recent Development
Table 102. Nordion (Canada) Corporation Information
Table 103. Nordion (Canada) Description and Major Businesses
Table 104. Nordion (Canada) Nuclear Medicine Radioisotopes Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 105. Nordion (Canada) Product
Table 106. Nordion (Canada) Recent Development
Table 107. NTP Radioisotopes SOC Corporation Information
Table 108. NTP Radioisotopes SOC Description and Major Businesses
Table 109. NTP Radioisotopes SOC Nuclear Medicine Radioisotopes Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 110. NTP Radioisotopes SOC Product
Table 111. NTP Radioisotopes SOC Recent Development
Table 112. Positron Corporation Information
Table 113. Positron Description and Major Businesses
Table 114. Positron Nuclear Medicine Radioisotopes Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 115. Positron Product
Table 116. Positron Recent Development
Table 117. Segami Corporation Information
Table 118. Segami Description and Major Businesses
Table 119. Segami Nuclear Medicine Radioisotopes Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 120. Segami Product
Table 121. Segami Recent Development
Table 122. Siemens Healthcare Corporation Information
Table 123. Siemens Healthcare Description and Major Businesses
Table 124. Siemens Healthcare Nuclear Medicine Radioisotopes Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 125. Siemens Healthcare Product
Table 126. Siemens Healthcare Recent Development
Table 127. Global Nuclear Medicine Radioisotopes Revenue Forecast by Region (2021-2026) (Million US$)
Table 128. Global Nuclear Medicine Radioisotopes Production Forecast by Regions (2021-2026) (K Units)
Table 129. Global Nuclear Medicine Radioisotopes Production Forecast by Type (2021-2026) (K Units)
Table 130. Global Nuclear Medicine Radioisotopes Revenue Forecast by Type (2021-2026) (Million US$)
Table 131. North America Nuclear Medicine Radioisotopes Consumption Forecast by Regions (2021-2026) (K Units)
Table 132. Europe Nuclear Medicine Radioisotopes Consumption Forecast by Regions (2021-2026) (K Units)
Table 133. Asia Pacific Nuclear Medicine Radioisotopes Consumption Forecast by Regions (2021-2026) (K Units)
Table 134. Latin America Nuclear Medicine Radioisotopes Consumption Forecast by Regions (2021-2026) (K Units)
Table 135. Middle East and Africa Nuclear Medicine Radioisotopes Consumption Forecast by Regions (2021-2026) (K Units)
Table 136. Nuclear Medicine Radioisotopes Distributors List
Table 137. Nuclear Medicine Radioisotopes Customers List
Table 138. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 139. Key Challenges
Table 140. Market Risks
Table 141. Research Programs/Design for This Report
Table 142. Key Data Information from Secondary Sources
Table 143. Key Data Information from Primary Sources
Table 1. Nuclear Medicine Radioisotopes Key Market Segments in This Study
Table 2. Ranking of Global Top Nuclear Medicine Radioisotopes Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Nuclear Medicine Radioisotopes Market Size Growth Rate by Type 2020-2026 (K Units) (Million US$)
Table 4. Major Manufacturers of Thallium-201 (Tl-201)
Table 5. Major Manufacturers of Iodine (I-123)
Table 6. Major Manufacturers of Fluorine-18
Table 7. Major Manufacturers of Rubidium-82 (Rb-82)
Table 8. Major Manufacturers of Other
Table 9. COVID-19 Impact Global Market: (Four Nuclear Medicine Radioisotopes Market Size Forecast Scenarios)
Table 10. Opportunities and Trends for Nuclear Medicine Radioisotopes Players in the COVID-19 Landscape
Table 11. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 12. Key Regions/Countries Measures against Covid-19 Impact
Table 13. Proposal for Nuclear Medicine Radioisotopes Players to Combat Covid-19 Impact
Table 14. Global Nuclear Medicine Radioisotopes Market Size Growth Rate by Application 2020-2026 (K Units)
Table 15. Global Nuclear Medicine Radioisotopes Market Size by Region in US$ Million: 2015 VS 2020 VS 2026
Table 16. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global Nuclear Medicine Radioisotopes by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Nuclear Medicine Radioisotopes as of 2019)
Table 18. Nuclear Medicine Radioisotopes Manufacturing Base Distribution and Headquarters
Table 19. Manufacturers Nuclear Medicine Radioisotopes Product Offered
Table 20. Date of Manufacturers Enter into Nuclear Medicine Radioisotopes Market
Table 21. Key Trends for Nuclear Medicine Radioisotopes Markets & Products
Table 22. Main Points Interviewed from Key Nuclear Medicine Radioisotopes Players
Table 23. Global Nuclear Medicine Radioisotopes Production Capacity by Manufacturers (2015-2020) (K Units)
Table 24. Global Nuclear Medicine Radioisotopes Production Share by Manufacturers (2015-2020)
Table 25. Nuclear Medicine Radioisotopes Revenue by Manufacturers (2015-2020) (Million US$)
Table 26. Nuclear Medicine Radioisotopes Revenue Share by Manufacturers (2015-2020)
Table 27. Nuclear Medicine Radioisotopes Price by Manufacturers 2015-2020 (USD/Unit)
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Nuclear Medicine Radioisotopes Production by Regions (2015-2020) (K Units)
Table 30. Global Nuclear Medicine Radioisotopes Production Market Share by Regions (2015-2020)
Table 31. Global Nuclear Medicine Radioisotopes Revenue by Regions (2015-2020) (US$ Million)
Table 32. Global Nuclear Medicine Radioisotopes Revenue Market Share by Regions (2015-2020)
Table 33. Key Nuclear Medicine Radioisotopes Players in North America
Table 34. Import & Export of Nuclear Medicine Radioisotopes in North America (K Units)
Table 35. Key Nuclear Medicine Radioisotopes Players in Europe
Table 36. Import & Export of Nuclear Medicine Radioisotopes in Europe (K Units)
Table 37. Key Nuclear Medicine Radioisotopes Players in China
Table 38. Import & Export of Nuclear Medicine Radioisotopes in China (K Units)
Table 39. Key Nuclear Medicine Radioisotopes Players in Japan
Table 40. Import & Export of Nuclear Medicine Radioisotopes in Japan (K Units)
Table 41. Global Nuclear Medicine Radioisotopes Consumption by Regions (2015-2020) (K Units)
Table 42. Global Nuclear Medicine Radioisotopes Consumption Market Share by Regions (2015-2020)
Table 43. North America Nuclear Medicine Radioisotopes Consumption by Application (2015-2020) (K Units)
Table 44. North America Nuclear Medicine Radioisotopes Consumption by Countries (2015-2020) (K Units)
Table 45. Europe Nuclear Medicine Radioisotopes Consumption by Application (2015-2020) (K Units)
Table 46. Europe Nuclear Medicine Radioisotopes Consumption by Countries (2015-2020) (K Units)
Table 47. Asia Pacific Nuclear Medicine Radioisotopes Consumption by Application (2015-2020) (K Units)
Table 48. Asia Pacific Nuclear Medicine Radioisotopes Consumption Market Share by Application (2015-2020) (K Units)
Table 49. Asia Pacific Nuclear Medicine Radioisotopes Consumption by Regions (2015-2020) (K Units)
Table 50. Latin America Nuclear Medicine Radioisotopes Consumption by Application (2015-2020) (K Units)
Table 51. Latin America Nuclear Medicine Radioisotopes Consumption by Countries (2015-2020) (K Units)
Table 52. Middle East and Africa Nuclear Medicine Radioisotopes Consumption by Application (2015-2020) (K Units)
Table 53. Middle East and Africa Nuclear Medicine Radioisotopes Consumption by Countries (2015-2020) (K Units)
Table 54. Global Nuclear Medicine Radioisotopes Production by Type (2015-2020) (K Units)
Table 55. Global Nuclear Medicine Radioisotopes Production Share by Type (2015-2020)
Table 56. Global Nuclear Medicine Radioisotopes Revenue by Type (2015-2020) (Million US$)
Table 57. Global Nuclear Medicine Radioisotopes Revenue Share by Type (2015-2020)
Table 58. Nuclear Medicine Radioisotopes Price by Type 2015-2020 (USD/Unit)
Table 59. Global Nuclear Medicine Radioisotopes Consumption by Application (2015-2020) (K Units)
Table 60. Global Nuclear Medicine Radioisotopes Consumption by Application (2015-2020) (K Units)
Table 61. Global Nuclear Medicine Radioisotopes Consumption Share by Application (2015-2020)
Table 62. Agfa-Gevaert Group Corporation Information
Table 63. Agfa-Gevaert Group Description and Major Businesses
Table 64. Agfa-Gevaert Group Nuclear Medicine Radioisotopes Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 65. Agfa-Gevaert Group Product
Table 66. Agfa-Gevaert Group Recent Development
Table 67. Braco Corporation Information
Table 68. Braco Description and Major Businesses
Table 69. Braco Nuclear Medicine Radioisotopes Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 70. Braco Product
Table 71. Braco Recent Development
Table 72. Cardiarc Corporation Information
Table 73. Cardiarc Description and Major Businesses
Table 74. Cardiarc Nuclear Medicine Radioisotopes Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 75. Cardiarc Product
Table 76. Cardiarc Recent Development
Table 77. Cardinal Health Corporation Information
Table 78. Cardinal Health Description and Major Businesses
Table 79. Cardinal Health Nuclear Medicine Radioisotopes Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 80. Cardinal Health Product
Table 81. Cardinal Health Recent Development
Table 82. CMR Naviscan (Gamma Medica Inc.) Corporation Information
Table 83. CMR Naviscan (Gamma Medica Inc.) Description and Major Businesses
Table 84. CMR Naviscan (Gamma Medica Inc.) Nuclear Medicine Radioisotopes Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 85. CMR Naviscan (Gamma Medica Inc.) Product
Table 86. CMR Naviscan (Gamma Medica Inc.) Recent Development
Table 87. Curium Corporation Information
Table 88. Curium Description and Major Businesses
Table 89. Curium Nuclear Medicine Radioisotopes Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 90. Curium Product
Table 91. Curium Recent Development
Table 92. Digirad Corporation Information
Table 93. Digirad Description and Major Businesses
Table 94. Digirad Nuclear Medicine Radioisotopes Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 95. Digirad Product
Table 96. Digirad Recent Development
Table 97. GE Healthcare Corporation Information
Table 98. GE Healthcare Description and Major Businesses
Table 99. GE Healthcare Nuclear Medicine Radioisotopes Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 100. GE Healthcare Product
Table 101. GE Healthcare Recent Development
Table 102. Nordion (Canada) Corporation Information
Table 103. Nordion (Canada) Description and Major Businesses
Table 104. Nordion (Canada) Nuclear Medicine Radioisotopes Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 105. Nordion (Canada) Product
Table 106. Nordion (Canada) Recent Development
Table 107. NTP Radioisotopes SOC Corporation Information
Table 108. NTP Radioisotopes SOC Description and Major Businesses
Table 109. NTP Radioisotopes SOC Nuclear Medicine Radioisotopes Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 110. NTP Radioisotopes SOC Product
Table 111. NTP Radioisotopes SOC Recent Development
Table 112. Positron Corporation Information
Table 113. Positron Description and Major Businesses
Table 114. Positron Nuclear Medicine Radioisotopes Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 115. Positron Product
Table 116. Positron Recent Development
Table 117. Segami Corporation Information
Table 118. Segami Description and Major Businesses
Table 119. Segami Nuclear Medicine Radioisotopes Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 120. Segami Product
Table 121. Segami Recent Development
Table 122. Siemens Healthcare Corporation Information
Table 123. Siemens Healthcare Description and Major Businesses
Table 124. Siemens Healthcare Nuclear Medicine Radioisotopes Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 125. Siemens Healthcare Product
Table 126. Siemens Healthcare Recent Development
Table 127. Global Nuclear Medicine Radioisotopes Revenue Forecast by Region (2021-2026) (Million US$)
Table 128. Global Nuclear Medicine Radioisotopes Production Forecast by Regions (2021-2026) (K Units)
Table 129. Global Nuclear Medicine Radioisotopes Production Forecast by Type (2021-2026) (K Units)
Table 130. Global Nuclear Medicine Radioisotopes Revenue Forecast by Type (2021-2026) (Million US$)
Table 131. North America Nuclear Medicine Radioisotopes Consumption Forecast by Regions (2021-2026) (K Units)
Table 132. Europe Nuclear Medicine Radioisotopes Consumption Forecast by Regions (2021-2026) (K Units)
Table 133. Asia Pacific Nuclear Medicine Radioisotopes Consumption Forecast by Regions (2021-2026) (K Units)
Table 134. Latin America Nuclear Medicine Radioisotopes Consumption Forecast by Regions (2021-2026) (K Units)
Table 135. Middle East and Africa Nuclear Medicine Radioisotopes Consumption Forecast by Regions (2021-2026) (K Units)
Table 136. Nuclear Medicine Radioisotopes Distributors List
Table 137. Nuclear Medicine Radioisotopes Customers List
Table 138. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 139. Key Challenges
Table 140. Market Risks
Table 141. Research Programs/Design for This Report
Table 142. Key Data Information from Secondary Sources
Table 143. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Nuclear Medicine Radioisotopes Product Picture
Figure 2. Global Nuclear Medicine Radioisotopes Production Market Share by Type in 2020 & 2026
Figure 3. Thallium-201 (Tl-201) Product Picture
Figure 4. Iodine (I-123) Product Picture
Figure 5. Fluorine-18 Product Picture
Figure 6. Rubidium-82 (Rb-82) Product Picture
Figure 7. Other Product Picture
Figure 8. Global Nuclear Medicine Radioisotopes Consumption Market Share by Application in 2020 & 2026
Figure 9. Tumor
Figure 10. Heart Disease
Figure 11. Lymphoma
Figure 12. Thyroid Gland
Figure 13. Other
Figure 14. Nuclear Medicine Radioisotopes Report Years Considered
Figure 15. Global Nuclear Medicine Radioisotopes Revenue 2015-2026 (Million US$)
Figure 16. Global Nuclear Medicine Radioisotopes Production Capacity 2015-2026 (K Units)
Figure 17. Global Nuclear Medicine Radioisotopes Production 2015-2026 (K Units)
Figure 18. Global Nuclear Medicine Radioisotopes Market Share Scenario by Region in Percentage: 2020 Versus 2026
Figure 19. Nuclear Medicine Radioisotopes Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 20. Global Nuclear Medicine Radioisotopes Production Share by Manufacturers in 2015
Figure 21. The Top 10 and Top 5 Players Market Share by Nuclear Medicine Radioisotopes Revenue in 2019
Figure 22. Global Nuclear Medicine Radioisotopes Production Market Share by Region (2015-2020)
Figure 23. Nuclear Medicine Radioisotopes Production Growth Rate in North America (2015-2020) (K Units)
Figure 24. Nuclear Medicine Radioisotopes Revenue Growth Rate in North America (2015-2020) (US$ Million)
Figure 25. Nuclear Medicine Radioisotopes Production Growth Rate in Europe (2015-2020) (K Units)
Figure 26. Nuclear Medicine Radioisotopes Revenue Growth Rate in Europe (2015-2020) (US$ Million)
Figure 27. Nuclear Medicine Radioisotopes Production Growth Rate in China (2015-2020) (K Units)
Figure 28. Nuclear Medicine Radioisotopes Revenue Growth Rate in China (2015-2020) (US$ Million)
Figure 29. Nuclear Medicine Radioisotopes Production Growth Rate in Japan (2015-2020) (K Units)
Figure 30. Nuclear Medicine Radioisotopes Revenue Growth Rate in Japan (2015-2020) (US$ Million)
Figure 31. Global Nuclear Medicine Radioisotopes Consumption Market Share by Regions 2015-2020
Figure 32. North America Nuclear Medicine Radioisotopes Consumption and Growth Rate (2015-2020) (K Units)
Figure 33. North America Nuclear Medicine Radioisotopes Consumption Market Share by Application in 2019
Figure 34. North America Nuclear Medicine Radioisotopes Consumption Market Share by Countries in 2019
Figure 35. U.S. Nuclear Medicine Radioisotopes Consumption and Growth Rate (2015-2020) (K Units)
Figure 36. Canada Nuclear Medicine Radioisotopes Consumption and Growth Rate (2015-2020) (K Units)
Figure 37. Europe Nuclear Medicine Radioisotopes Consumption and Growth Rate (2015-2020) (K Units)
Figure 38. Europe Nuclear Medicine Radioisotopes Consumption Market Share by Application in 2019
Figure 39. Europe Nuclear Medicine Radioisotopes Consumption Market Share by Countries in 2019
Figure 40. Germany Nuclear Medicine Radioisotopes Consumption and Growth Rate (2015-2020) (K Units)
Figure 41. France Nuclear Medicine Radioisotopes Consumption and Growth Rate (2015-2020) (K Units)
Figure 42. U.K. Nuclear Medicine Radioisotopes Consumption and Growth Rate (2015-2020) (K Units)
Figure 43. Italy Nuclear Medicine Radioisotopes Consumption and Growth Rate (2015-2020) (K Units)
Figure 44. Russia Nuclear Medicine Radioisotopes Consumption and Growth Rate (2015-2020) (K Units)
Figure 45. Asia Pacific Nuclear Medicine Radioisotopes Consumption and Growth Rate (K Units)
Figure 46. Asia Pacific Nuclear Medicine Radioisotopes Consumption Market Share by Application in 2019
Figure 47. Asia Pacific Nuclear Medicine Radioisotopes Consumption Market Share by Regions in 2019
Figure 48. China Nuclear Medicine Radioisotopes Consumption and Growth Rate (2015-2020) (K Units)
Figure 49. Japan Nuclear Medicine Radioisotopes Consumption and Growth Rate (2015-2020) (K Units)
Figure 50. South Korea Nuclear Medicine Radioisotopes Consumption and Growth Rate (2015-2020) (K Units)
Figure 51. India Nuclear Medicine Radioisotopes Consumption and Growth Rate (2015-2020) (K Units)
Figure 52. Australia Nuclear Medicine Radioisotopes Consumption and Growth Rate (2015-2020) (K Units)
Figure 53. Taiwan Nuclear Medicine Radioisotopes Consumption and Growth Rate (2015-2020) (K Units)
Figure 54. Indonesia Nuclear Medicine Radioisotopes Consumption and Growth Rate (2015-2020) (K Units)
Figure 55. Thailand Nuclear Medicine Radioisotopes Consumption and Growth Rate (2015-2020) (K Units)
Figure 56. Malaysia Nuclear Medicine Radioisotopes Consumption and Growth Rate (2015-2020) (K Units)
Figure 57. Philippines Nuclear Medicine Radioisotopes Consumption and Growth Rate (2015-2020) (K Units)
Figure 58. Vietnam Nuclear Medicine Radioisotopes Consumption and Growth Rate (2015-2020) (K Units)
Figure 59. Latin America Nuclear Medicine Radioisotopes Consumption and Growth Rate (K Units)
Figure 60. Latin America Nuclear Medicine Radioisotopes Consumption Market Share by Application in 2019
Figure 61. Latin America Nuclear Medicine Radioisotopes Consumption Market Share by Countries in 2019
Figure 62. Mexico Nuclear Medicine Radioisotopes Consumption and Growth Rate (2015-2020) (K Units)
Figure 63. Brazil Nuclear Medicine Radioisotopes Consumption and Growth Rate (2015-2020) (K Units)
Figure 64. Argentina Nuclear Medicine Radioisotopes Consumption and Growth Rate (2015-2020) (K Units)
Figure 65. Middle East and Africa Nuclear Medicine Radioisotopes Consumption and Growth Rate (K Units)
Figure 66. Middle East and Africa Nuclear Medicine Radioisotopes Consumption Market Share by Application in 2019
Figure 67. Middle East and Africa Nuclear Medicine Radioisotopes Consumption Market Share by Countries in 2019
Figure 68. Turkey Nuclear Medicine Radioisotopes Consumption and Growth Rate (2015-2020) (K Units)
Figure 69. Saudi Arabia Nuclear Medicine Radioisotopes Consumption and Growth Rate (2015-2020) (K Units)
Figure 70. U.A.E Nuclear Medicine Radioisotopes Consumption and Growth Rate (2015-2020) (K Units)
Figure 71. Global Nuclear Medicine Radioisotopes Production Market Share by Type (2015-2020)
Figure 72. Global Nuclear Medicine Radioisotopes Production Market Share by Type in 2019
Figure 73. Global Nuclear Medicine Radioisotopes Revenue Market Share by Type (2015-2020)
Figure 74. Global Nuclear Medicine Radioisotopes Revenue Market Share by Type in 2019
Figure 75. Global Nuclear Medicine Radioisotopes Production Market Share Forecast by Type (2021-2026)
Figure 76. Global Nuclear Medicine Radioisotopes Revenue Market Share Forecast by Type (2021-2026)
Figure 77. Global Nuclear Medicine Radioisotopes Market Share by Price Range (2015-2020)
Figure 78. Global Nuclear Medicine Radioisotopes Consumption Market Share by Application (2015-2020)
Figure 79. Global Nuclear Medicine Radioisotopes Value (Consumption) Market Share by Application (2015-2020)
Figure 80. Global Nuclear Medicine Radioisotopes Consumption Market Share Forecast by Application (2021-2026)
Figure 81. Agfa-Gevaert Group Total Revenue (US$ Million): 2019 Compared with 2018
Figure 82. Braco Total Revenue (US$ Million): 2019 Compared with 2018
Figure 83. Cardiarc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 84. Cardinal Health Total Revenue (US$ Million): 2019 Compared with 2018
Figure 85. CMR Naviscan (Gamma Medica Inc.) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 86. Curium Total Revenue (US$ Million): 2019 Compared with 2018
Figure 87. Digirad Total Revenue (US$ Million): 2019 Compared with 2018
Figure 88. GE Healthcare Total Revenue (US$ Million): 2019 Compared with 2018
Figure 89. Nordion (Canada) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 90. NTP Radioisotopes SOC Total Revenue (US$ Million): 2019 Compared with 2018
Figure 91. Positron Total Revenue (US$ Million): 2019 Compared with 2018
Figure 92. Segami Total Revenue (US$ Million): 2019 Compared with 2018
Figure 93. Siemens Healthcare Total Revenue (US$ Million): 2019 Compared with 2018
Figure 94. Global Nuclear Medicine Radioisotopes Revenue Forecast by Regions (2021-2026) (US$ Million)
Figure 95. Global Nuclear Medicine Radioisotopes Revenue Market Share Forecast by Regions ((2021-2026))
Figure 96. Global Nuclear Medicine Radioisotopes Production Forecast by Regions (2021-2026) (K Units)
Figure 97. North America Nuclear Medicine Radioisotopes Production Forecast (2021-2026) (K Units)
Figure 98. North America Nuclear Medicine Radioisotopes Revenue Forecast (2021-2026) (US$ Million)
Figure 99. Europe Nuclear Medicine Radioisotopes Production Forecast (2021-2026) (K Units)
Figure 100. Europe Nuclear Medicine Radioisotopes Revenue Forecast (2021-2026) (US$ Million)
Figure 101. China Nuclear Medicine Radioisotopes Production Forecast (2021-2026) (K Units)
Figure 102. China Nuclear Medicine Radioisotopes Revenue Forecast (2021-2026) (US$ Million)
Figure 103. Japan Nuclear Medicine Radioisotopes Production Forecast (2021-2026) (K Units)
Figure 104. Japan Nuclear Medicine Radioisotopes Revenue Forecast (2021-2026) (US$ Million)
Figure 105. Global Nuclear Medicine Radioisotopes Consumption Market Share Forecast by Region (2021-2026)
Figure 106. Nuclear Medicine Radioisotopes Value Chain
Figure 107. Channels of Distribution
Figure 108. Distributors Profiles
Figure 109. Porter's Five Forces Analysis
Figure 110. Bottom-up and Top-down Approaches for This Report
Figure 111. Data Triangulation
Figure 112. Key Executives Interviewed
Figure 1. Nuclear Medicine Radioisotopes Product Picture
Figure 2. Global Nuclear Medicine Radioisotopes Production Market Share by Type in 2020 & 2026
Figure 3. Thallium-201 (Tl-201) Product Picture
Figure 4. Iodine (I-123) Product Picture
Figure 5. Fluorine-18 Product Picture
Figure 6. Rubidium-82 (Rb-82) Product Picture
Figure 7. Other Product Picture
Figure 8. Global Nuclear Medicine Radioisotopes Consumption Market Share by Application in 2020 & 2026
Figure 9. Tumor
Figure 10. Heart Disease
Figure 11. Lymphoma
Figure 12. Thyroid Gland
Figure 13. Other
Figure 14. Nuclear Medicine Radioisotopes Report Years Considered
Figure 15. Global Nuclear Medicine Radioisotopes Revenue 2015-2026 (Million US$)
Figure 16. Global Nuclear Medicine Radioisotopes Production Capacity 2015-2026 (K Units)
Figure 17. Global Nuclear Medicine Radioisotopes Production 2015-2026 (K Units)
Figure 18. Global Nuclear Medicine Radioisotopes Market Share Scenario by Region in Percentage: 2020 Versus 2026
Figure 19. Nuclear Medicine Radioisotopes Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 20. Global Nuclear Medicine Radioisotopes Production Share by Manufacturers in 2015
Figure 21. The Top 10 and Top 5 Players Market Share by Nuclear Medicine Radioisotopes Revenue in 2019
Figure 22. Global Nuclear Medicine Radioisotopes Production Market Share by Region (2015-2020)
Figure 23. Nuclear Medicine Radioisotopes Production Growth Rate in North America (2015-2020) (K Units)
Figure 24. Nuclear Medicine Radioisotopes Revenue Growth Rate in North America (2015-2020) (US$ Million)
Figure 25. Nuclear Medicine Radioisotopes Production Growth Rate in Europe (2015-2020) (K Units)
Figure 26. Nuclear Medicine Radioisotopes Revenue Growth Rate in Europe (2015-2020) (US$ Million)
Figure 27. Nuclear Medicine Radioisotopes Production Growth Rate in China (2015-2020) (K Units)
Figure 28. Nuclear Medicine Radioisotopes Revenue Growth Rate in China (2015-2020) (US$ Million)
Figure 29. Nuclear Medicine Radioisotopes Production Growth Rate in Japan (2015-2020) (K Units)
Figure 30. Nuclear Medicine Radioisotopes Revenue Growth Rate in Japan (2015-2020) (US$ Million)
Figure 31. Global Nuclear Medicine Radioisotopes Consumption Market Share by Regions 2015-2020
Figure 32. North America Nuclear Medicine Radioisotopes Consumption and Growth Rate (2015-2020) (K Units)
Figure 33. North America Nuclear Medicine Radioisotopes Consumption Market Share by Application in 2019
Figure 34. North America Nuclear Medicine Radioisotopes Consumption Market Share by Countries in 2019
Figure 35. U.S. Nuclear Medicine Radioisotopes Consumption and Growth Rate (2015-2020) (K Units)
Figure 36. Canada Nuclear Medicine Radioisotopes Consumption and Growth Rate (2015-2020) (K Units)
Figure 37. Europe Nuclear Medicine Radioisotopes Consumption and Growth Rate (2015-2020) (K Units)
Figure 38. Europe Nuclear Medicine Radioisotopes Consumption Market Share by Application in 2019
Figure 39. Europe Nuclear Medicine Radioisotopes Consumption Market Share by Countries in 2019
Figure 40. Germany Nuclear Medicine Radioisotopes Consumption and Growth Rate (2015-2020) (K Units)
Figure 41. France Nuclear Medicine Radioisotopes Consumption and Growth Rate (2015-2020) (K Units)
Figure 42. U.K. Nuclear Medicine Radioisotopes Consumption and Growth Rate (2015-2020) (K Units)
Figure 43. Italy Nuclear Medicine Radioisotopes Consumption and Growth Rate (2015-2020) (K Units)
Figure 44. Russia Nuclear Medicine Radioisotopes Consumption and Growth Rate (2015-2020) (K Units)
Figure 45. Asia Pacific Nuclear Medicine Radioisotopes Consumption and Growth Rate (K Units)
Figure 46. Asia Pacific Nuclear Medicine Radioisotopes Consumption Market Share by Application in 2019
Figure 47. Asia Pacific Nuclear Medicine Radioisotopes Consumption Market Share by Regions in 2019
Figure 48. China Nuclear Medicine Radioisotopes Consumption and Growth Rate (2015-2020) (K Units)
Figure 49. Japan Nuclear Medicine Radioisotopes Consumption and Growth Rate (2015-2020) (K Units)
Figure 50. South Korea Nuclear Medicine Radioisotopes Consumption and Growth Rate (2015-2020) (K Units)
Figure 51. India Nuclear Medicine Radioisotopes Consumption and Growth Rate (2015-2020) (K Units)
Figure 52. Australia Nuclear Medicine Radioisotopes Consumption and Growth Rate (2015-2020) (K Units)
Figure 53. Taiwan Nuclear Medicine Radioisotopes Consumption and Growth Rate (2015-2020) (K Units)
Figure 54. Indonesia Nuclear Medicine Radioisotopes Consumption and Growth Rate (2015-2020) (K Units)
Figure 55. Thailand Nuclear Medicine Radioisotopes Consumption and Growth Rate (2015-2020) (K Units)
Figure 56. Malaysia Nuclear Medicine Radioisotopes Consumption and Growth Rate (2015-2020) (K Units)
Figure 57. Philippines Nuclear Medicine Radioisotopes Consumption and Growth Rate (2015-2020) (K Units)
Figure 58. Vietnam Nuclear Medicine Radioisotopes Consumption and Growth Rate (2015-2020) (K Units)
Figure 59. Latin America Nuclear Medicine Radioisotopes Consumption and Growth Rate (K Units)
Figure 60. Latin America Nuclear Medicine Radioisotopes Consumption Market Share by Application in 2019
Figure 61. Latin America Nuclear Medicine Radioisotopes Consumption Market Share by Countries in 2019
Figure 62. Mexico Nuclear Medicine Radioisotopes Consumption and Growth Rate (2015-2020) (K Units)
Figure 63. Brazil Nuclear Medicine Radioisotopes Consumption and Growth Rate (2015-2020) (K Units)
Figure 64. Argentina Nuclear Medicine Radioisotopes Consumption and Growth Rate (2015-2020) (K Units)
Figure 65. Middle East and Africa Nuclear Medicine Radioisotopes Consumption and Growth Rate (K Units)
Figure 66. Middle East and Africa Nuclear Medicine Radioisotopes Consumption Market Share by Application in 2019
Figure 67. Middle East and Africa Nuclear Medicine Radioisotopes Consumption Market Share by Countries in 2019
Figure 68. Turkey Nuclear Medicine Radioisotopes Consumption and Growth Rate (2015-2020) (K Units)
Figure 69. Saudi Arabia Nuclear Medicine Radioisotopes Consumption and Growth Rate (2015-2020) (K Units)
Figure 70. U.A.E Nuclear Medicine Radioisotopes Consumption and Growth Rate (2015-2020) (K Units)
Figure 71. Global Nuclear Medicine Radioisotopes Production Market Share by Type (2015-2020)
Figure 72. Global Nuclear Medicine Radioisotopes Production Market Share by Type in 2019
Figure 73. Global Nuclear Medicine Radioisotopes Revenue Market Share by Type (2015-2020)
Figure 74. Global Nuclear Medicine Radioisotopes Revenue Market Share by Type in 2019
Figure 75. Global Nuclear Medicine Radioisotopes Production Market Share Forecast by Type (2021-2026)
Figure 76. Global Nuclear Medicine Radioisotopes Revenue Market Share Forecast by Type (2021-2026)
Figure 77. Global Nuclear Medicine Radioisotopes Market Share by Price Range (2015-2020)
Figure 78. Global Nuclear Medicine Radioisotopes Consumption Market Share by Application (2015-2020)
Figure 79. Global Nuclear Medicine Radioisotopes Value (Consumption) Market Share by Application (2015-2020)
Figure 80. Global Nuclear Medicine Radioisotopes Consumption Market Share Forecast by Application (2021-2026)
Figure 81. Agfa-Gevaert Group Total Revenue (US$ Million): 2019 Compared with 2018
Figure 82. Braco Total Revenue (US$ Million): 2019 Compared with 2018
Figure 83. Cardiarc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 84. Cardinal Health Total Revenue (US$ Million): 2019 Compared with 2018
Figure 85. CMR Naviscan (Gamma Medica Inc.) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 86. Curium Total Revenue (US$ Million): 2019 Compared with 2018
Figure 87. Digirad Total Revenue (US$ Million): 2019 Compared with 2018
Figure 88. GE Healthcare Total Revenue (US$ Million): 2019 Compared with 2018
Figure 89. Nordion (Canada) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 90. NTP Radioisotopes SOC Total Revenue (US$ Million): 2019 Compared with 2018
Figure 91. Positron Total Revenue (US$ Million): 2019 Compared with 2018
Figure 92. Segami Total Revenue (US$ Million): 2019 Compared with 2018
Figure 93. Siemens Healthcare Total Revenue (US$ Million): 2019 Compared with 2018
Figure 94. Global Nuclear Medicine Radioisotopes Revenue Forecast by Regions (2021-2026) (US$ Million)
Figure 95. Global Nuclear Medicine Radioisotopes Revenue Market Share Forecast by Regions ((2021-2026))
Figure 96. Global Nuclear Medicine Radioisotopes Production Forecast by Regions (2021-2026) (K Units)
Figure 97. North America Nuclear Medicine Radioisotopes Production Forecast (2021-2026) (K Units)
Figure 98. North America Nuclear Medicine Radioisotopes Revenue Forecast (2021-2026) (US$ Million)
Figure 99. Europe Nuclear Medicine Radioisotopes Production Forecast (2021-2026) (K Units)
Figure 100. Europe Nuclear Medicine Radioisotopes Revenue Forecast (2021-2026) (US$ Million)
Figure 101. China Nuclear Medicine Radioisotopes Production Forecast (2021-2026) (K Units)
Figure 102. China Nuclear Medicine Radioisotopes Revenue Forecast (2021-2026) (US$ Million)
Figure 103. Japan Nuclear Medicine Radioisotopes Production Forecast (2021-2026) (K Units)
Figure 104. Japan Nuclear Medicine Radioisotopes Revenue Forecast (2021-2026) (US$ Million)
Figure 105. Global Nuclear Medicine Radioisotopes Consumption Market Share Forecast by Region (2021-2026)
Figure 106. Nuclear Medicine Radioisotopes Value Chain
Figure 107. Channels of Distribution
Figure 108. Distributors Profiles
Figure 109. Porter's Five Forces Analysis
Figure 110. Bottom-up and Top-down Approaches for This Report
Figure 111. Data Triangulation
Figure 112. Key Executives Interviewed
